This metabolite provides a PDE selectivity profile similar to sildenafil and an in vitro potency for PDE5 around 50% of the guardian drug. Plasma concentrations of the metabolite are close to 40% of All those noticed for sildenafil, so that the metabolite accounts for around twenty% of sildenafil’s pharmacologic effects.Sildenafil should not be t